Jeanne Loring
Jeanne Frances Loring (born May 4, 1950) is an American stem cell biologist, developmental neurobiologist, and geneticist.
She is the founding Director of the Center for Regenerative Medicine and emeritus professor at the Scripps Research Institute in La Jolla, California.
In 1968, Loring was selected for a National Merit Scholarship, which allowed her to attend the University of Washington in Seattle, where she completed a bachelor of science degree, magna cum laude, in molecular biology in 1972[1] and was elected to Phi Beta Kappa.
After completing her doctoral work, Loring spent five years studying and lecturing on embryology and neurobiology at UC Davis before moving to the biotechnology industry.
As Staff Scientist at Hana Biologics (1987-1989), Loring worked on development of cell therapy for Parkinson's disease.
[8][9][10] The Wisconsin Alumni Foundation (WARF) was issued a composition of matter patent in 2001 that covered all human embryonic stem cells, and because of high patent licensing fees, Arcos decided to merge with another small company, Cythera,[11] which then merged with another stem cell company, Bresagen.
[12] After another merger with Novocell, the company became Viacyte,[13] which was acquired by Vertex in 2022[14] for its experience in development of stem cell-derived therapies for Type 1 Diabetes.
[17] In 2019, she moved her lab and research projects to Aspen Neuroscience, a biotechnology company she founded in 2018 with her postdoctoral fellow, Andres Bratt-Leal.
[21] She was also an adjunct professor in human genetics at Sanford Burnham Prebys Institute, and remains an adjunct professor in the School of Public Health at San Diego State University, and Research Fellow at the Zoological Society of San Diego.
[23] Loring is an advocate for patient education and against stem cell tourism, and has frequently spoken out on these subjects[24] including commentaries in ethics journals with bioethicist Mary Devereaux.
[25][26] She has also commented on the ethics of stem cell research in articles with ethicist Jonathan Moreno[27] and pro-life advocate Christine Scheller.
[42] IPSCs were generated from a primate, the drill Mandrillus leucophaeus and the nearly extinct northern white rhinoceros, Ceratotherium simum cottoni.
There are only two northern white rhinos left in the world (2022), and the hope is that the iPSCs can be differentiated into sperm and egg cells to generate new animals.
She is a member of Phi Beta Kappa, and was inducted as an American Institute for Medical and Biological Engineering (AIMBE) Fellow in 2021.
In 2017, she was invited to join an international group of researchers working toward development of cell replacement therapies for Parkinson's disease, called G-Force PD.
